Fu-Dong Shi is a neurologist specialized with management of patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), myasthenia gravis, inflammatory neuropathy. He completed his clinical and research training in Harbin Medical University, Peking Union Hospital, China, Karolinska Institute, Sweden, The Scripps Research Institute, California, USA, and Barrow Neurological Institute, Arizona, USA. Dr. Shi studies the specific features of initiation, propagation of inflammatory and immune responses of the central nervous system (CNS), as well as therapeutic modulation of CNS inflammation in patients with MS/NMOSD, stroke and corresponding animal models. Dr. Shi has served as PI for a number of clinical trials and advanced a number of disease modifying therapies for MS/NMOSD with special considerations of China. Dr. Shi has published 180 articles and is serving on editorial board of Science Translational Medicine.